Hydroxyethylstarch as a replacement fluid in therapeutic plasma exchange for lupus nephritis in a Jehovah's Witness. （開啟新視窗）

Cid J, Ortín X, Elies E, Díaz E.

出處‎: Transfus Apher Sci 2003;28(1):101-2.

檢索‎: PubMed 12620275

DOI碼‎: 10.1016/S1473-0502(02)00105-2

https://www.ncbi.nlm.nih.gov/pubmed/12620275 （開啟新視窗）

Successful management of a Jehovah's Witness with thrombotic thrombocytopenic purpura unwilling to be treated with therapeutic plasma exchange. （開啟新視窗）

Dabak V, Kuriakose P, Raman S.

出處‎: J Clin Apher 2007;22(6):330-2.

檢索‎: PubMed 18080270

DOI碼‎: 10.1002/jca.20150

https://www.ncbi.nlm.nih.gov/pubmed/18080270 （開啟新視窗）

Bovine hemoglobin: a nontraditional approach to the management of acute anemia in a Jehovah's Witness patient with autoimmune hemolytic anemia. （開啟新視窗）

Jordan SD, Alexander E.

出處‎: J Pharm Pract 2013;26(3):257-60.

檢索‎: PubMed 22869910

DOI碼‎: 10.1177/0897190012451928

https://www.ncbi.nlm.nih.gov/pubmed/22869910 （開啟新視窗）

The treatment of acute lymphoblastic leukemia in Jehovah's Witnesses and patients who cannot accept blood products. （開啟新視窗）

Nguyen N, Madarang E, Alencar A, Watts J, Bradley T

出處‎: Leuk Res Rep. 2022 25;18:100355.

檢索‎: PubMed 36338830

DOI碼‎: 10.1016/j.lrr.2022.100355

https://pubmed.ncbi.nlm.nih.gov/36338830/ （開啟新視窗）

The use of recombinant factor VIIa in a Jehovah's Witness with auto-immune thrombocytopenia and post-splenectomy haemorrhage. （開啟新視窗）

Waddington DP, McAuley FT, Hanley JP, Summerfield GP.

出處‎: Br J Haematol 2002;119(1):286-8.

檢索‎: PubMed 12358947

https://www.ncbi.nlm.nih.gov/pubmed/12358947 （開啟新視窗）

Thrombotic thrombocytopenic purpura treated with vincristine in a Jehovah's Witness. （開啟新視窗）

Walia SS, Walia MS, Walia HS.

出處‎: Asian J Transfus Sci 2011;5(2):180-1.

檢索‎: PubMed 21897605

DOI碼‎: 10.4103/0973-6247.83255

https://www.ncbi.nlm.nih.gov/pubmed/21897605 （開啟新視窗）